Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes

Diabetes Research and Clinical Practice - Tập 94 - Trang 426-433 - 2011
Ufuk Ozuguz1, Serhat Isik1, Dilek Berker1, Ayse Arduc1, Yasemin Tutuncu1, Gulhan Akbaba1, Ferhat Gokay1, Serdar Guler1
1Ministry of Health, Ankara Numune Research and Training Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey

Tài liệu tham khảo

American Diabetes Association, 2003, Gestational diabetes mellitus, Diabetes Care, 26, 103, 10.2337/diacare.26.2007.S103 O'Sullivan, 1991, Diabetes mellitus after GDM, Diabetes, 40, 131, 10.2337/diab.40.2.S131 Kim, 2002, Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care, 25, 1862, 10.2337/diacare.25.10.1862 Carpenter, 1982, Criteria for screening tests for gestational diabetes, Am J Obstet Gynecol, 144, 768, 10.1016/0002-9378(82)90349-0 Festa, 2000, Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS), Circulation, 102, 42, 10.1161/01.CIR.102.1.42 Ford, 1999, Body mass index, diabetes, and C-reactive protein among US adults, Diabetes Care, 22, 1971, 10.2337/diacare.22.12.1971 Pickup, 1997, NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X, Diabetologia, 40, 1286, 10.1007/s001250050822 Tsigos, 1997, Dose dependent effects of recombinant human interleukin-6 on glucose regulation, J Clin Endocrinol Metab, 82, 4167, 10.1210/jcem.82.12.4422 Stith, 1994, Endocrine and carbohydrate responses to interleukin-6 in vivo, Circ Shock, 44, 210 Festa, 2000, Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study, Kidney Int, 58, 1703, 10.1046/j.1523-1755.2000.00331.x Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–51. Cao, 2007, Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study, Circulation, 116, 32, 10.1161/CIRCULATIONAHA.106.645606 Wang, 2002, Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study, Arterioscler Thromb Vasc Biol, 22, 1662, 10.1161/01.ATV.0000034543.78801.69 Kivimäki, 2005, Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study, Arterioscler Thromb Vasc Biol, 25, 2197, 10.1161/01.ATV.0000183729.91449.6e Tremblay, 2004, Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population, Clin Biochem, 37, 785, 10.1016/j.clinbiochem.2004.03.008 Howard, 1993, Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound ARIC Investigators, Stroke, 24, 1297, 10.1161/01.STR.24.9.1297 Buchanan, 1999, Gestational diabetes: risk or myth?, J Clin Endocrinol Metab, 84, 1854, 10.1210/jcem.84.6.5714 Catalano, 1999, Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus, Am J Obstet Gynecol, 180, 903, 10.1016/S0002-9378(99)70662-9 Metzger, 1993, Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus, Diabetes Care, 16, 1598, 10.2337/diacare.16.12.1598 Schmidt, 1999, Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study, Lancet, 353, 1649, 10.1016/S0140-6736(99)01046-6 Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327 Kern, 2001, Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance, Am J Physiol Endocrinol Metab, 280, 745, 10.1152/ajpendo.2001.280.5.E745 Freeman, 2002, West of Scotland Coronary Prevention Study C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study, Diabetes, 51, 1596, 10.2337/diabetes.51.5.1596 Barzilay, 2001, The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study, Diabetes, 50, 2384, 10.2337/diabetes.50.10.2384 Festa, 2002, Insulin Resistance Atherosclerosis Study elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study, Diabetes, 51, 1131, 10.2337/diabetes.51.4.1131 Wolf, 2003, First-trimester C-reactive protein and subsequent gestational diabetes, Diabetes Care, 26, 819, 10.2337/diacare.26.3.819 Retnakaran, 2003, C-reactive protein and gestational diabetes: the central role of maternal obesity, J Clin Endocrinol Metab, 88, 3507, 10.1210/jc.2003-030186 Di Benedetto, 2005, Inflammatory markers in women with a recent history of gestational diabetes mellitus, J Endocrinol Invest, 28, 34, 10.1007/BF03345527 Di Cianni, 2007, C-reactive protein and metabolic syndrome in women with previous gestational diabetes, Diabetes Metab Res Rev, 23, 135, 10.1002/dmrr.661 Winzer, 2004, Plasma adiponectin: insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus, Diabetes Care, 27, 1721, 10.2337/diacare.27.7.1721 Di Cianni, 2003, Intermediate metabolism in normal pregnancy and in gestational diabetes, Diabetes Metab Res Rev, 19, 259, 10.1002/dmrr.390 Yudkin, 1999, C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?, Arterioscler Thromb Vasc Biol, 19, 972, 10.1161/01.ATV.19.4.972 Hirsch, 2001, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, 1317, 10.1001/jama.286.11.1317 Magyar, 2003, Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers, Stroke, 34, 58, 10.1161/01.STR.0000048845.83285.AC Winbeck, 2002, Elevated Creactive protein is associated with an increased intima to media thickness of the common carotid artery, Cerebrovasc Dis, 13, 57, 10.1159/000047747 Tarim, 2006, Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus, Ultrasound Obstet Gynecol, 27, 177, 10.1002/uog.2687 Brownlee, 1994, Lilly Lecture 1993 Glycation and diabetic complications, Diabetes, 43, 836, 10.2337/diab.43.6.836 Esposito, 2002, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress, Circulation, 106, 2067, 10.1161/01.CIR.0000034509.14906.AE Williams, 1998, Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo, Circulation, 97, 1695, 10.1161/01.CIR.97.17.1695 Mügge, 1991, Release of intact endothelium derived relaxing factor depends on endothelial superoxide dismutase activity, Am J Physiol, 260, 219, 10.1152/ajpcell.1991.260.2.C219 Rubanyi, 1986, Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle, Am J Physiol, 250, 815